Blueprint Medicines - 48 Year Dividend History | BPMC

Historical dividend payout and yield for Blueprint Medicines (BPMC) since 1971. The current TTM dividend payout for Blueprint Medicines (BPMC) as of April 22, 2019 is $0.00. The current dividend yield for Blueprint Medicines as of April 22, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $3.326B $0.045B
Blueprint Medicines Corp is an oncology company which is engaged in developing kinase inhibitors for genomically defined cancer subsets. Blueprint Medicines Corp is based in Cambridge, MA.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $108.629B 12.24
Gilead Sciences (GILD) United States $78.878B 10.04
Bio-Techne Corp (TECH) United States $7.219B 48.64